Senate Bill Seeks to Spare Small Biotechs from IRA’s Drug Price Negotiations

While unlikely to pass this year, given the Democrats’ control over the White House and Senate, the proposed legislation might be a harbinger of the Republicans’ agenda next year for the Inflation Reduction Act should they win the November elections.

Scroll to Top